<level type="section">
  <num>48-703</num>
  <heading>License requirements.</heading>
  <level>
    <num>(a)</num>
    <text>To obtain a license to manufacture, distribute, or wholesale any drug, any person who has a principal place of business in the District shall submit a completed application form with the required application fee to the Mayor and comply with the requirements of this chapter and the rules issued pursuant to this chapter.</text>
  </level>
  <level>
    <num>(b)</num>
    <text>If a person manufactures, distributes, or wholesales any drug at more than one place of business in the District, the person shall apply for a separate license for each place of business.</text>
  </level>
  <level>
    <num>(c)</num>
    <text>If a licensee manufactures, distributes, or wholesales a drug not listed on the application, the licensee shall notify the Mayor prior to the commencement of the activity.</text>
  </level>
  <level>
    <num>(d)</num>
    <text>If a licensee ceases to manufacture, distribute, or wholesale any drug listed in the application, the licensee shall notify the Mayor of the change no later than 7 days after ceasing the activity.</text>
  </level>
  <level>
    <num>(e)</num>
    <text>Each licensee shall maintain records as required by the Mayor, including but not limited to the quantities of each drug manufactured, distributed, or wholesaled daily and the name, address, purchaser, place of delivery, and quantity of any drug sold, transferred, or distributed by a licensee.</text>
  </level>
  <level>
    <num>(f)</num>
    <text>Any license issued pursuant to this section shall be issued as a Public Health: Pharmacy and Pharmaceuticals endorsement to a basic business license under the basic business license system as set forth in subchapter I-A of Chapter 28 of Title 47.</text>
  </level>
  <level type="annotations">
    <level>
      <heading>History</heading>
      <text>(June 13, 1990, D.C. Law 8-137, § 4, 37 DCR 2631; Apr. 20, 1999, D.C. Law 12-261, § 2003(ff), 46 DCR 3142; Oct. 28, 2003, D.C. Law 15-38, § 3(ii), 50 DCR 6913.)</text>
    </level>
    <level>
      <heading>Prior Codifications</heading>
      <text>1981 Ed., § 33-1003.</text>
    </level>
    <level>
      <heading>Effect of Amendments</heading>
      <text>D.C. Law 15-38, in subsec. (f), substituted "Public Health: Pharmacy and Pharmaceuticals endorsement to a basic business license under the basic" for "Class A Public Health: Pharmacy and Pharmaceuticals endorsement to a master business license under the master".</text>
    </level>
    <level>
      <heading>Emergency Legislation</heading>
      <text>For temporary (90 day) amendment of section, see § 3(ii) of Streamlining Regulation Emergency Act of 2003 (D.C. Act 15-145, August 11, 2003, 50 DCR 6896).</text>
    </level>
    <level>
      <heading>Legislative History of Law 8-137</heading>
      <text>For legislative history of D.C. Law 8-137, see Historical and Statutory Notes following § 48-701.</text>
    </level>
    <level>
      <heading>Legislative History of Law 12-261</heading>
      <text>Law 12-261, the "Second Omnibus Regulatory Reform Amendment Act of 1998," was introduced in Council and assigned Bill No. 12-615, which was referred to the Committee of the Whole. The Bill was adopted on first and second readings on December 1, 1998, and December 15, 1998, respectively. Signed by the Mayor on December 31, 1998, it was assigned Act No. 12-615 and transmitted to both Houses of Congress for its review. D.C. Law 12-261 became effective on April 20, 1999.</text>
    </level>
    <level>
      <heading>Legislative History of Law 15-38</heading>
      <text>Law 15-38, the "Streamlining Regulation Act of 2003", was introduced in Council and assigned Bill No. 15-19, which was referred to Committee on Consumer and Regulatory Affairs. The Bill was adopted on first and second readings on June 3, 2003, and July 8, 2003, respectively. Signed by the Mayor on August 11, 2003, it was assigned Act No. 15-146 and transmitted to both Houses of Congress for its review. D.C. Law 15-38 became effective on October 28, 2003.</text>
    </level>
  </level>
</level>
